bioAffinity Technologies, Inc. (BIAF) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
bioAffinity Technologies, Inc. (BIAF) operates in the Healthcare sector, specifically the Medical - Diagnostics & Research industry, with a market capitalization near $7.6M, listed on NASDAQ, employing roughly 57 people, carrying a beta of -1.19 to the broader market. bioAffinity Technologies, Inc. Led by Maria Zannes, public since 2022-09-01.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for BIAF as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.